Drug Search Results
More Filters [+]

Tasidotin

Alternative Names: tasidotin
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Ergomed Clinical Research
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tasidotin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Melanoma|Lymphoma, Non-Hodgkin

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2011-000124-15

P2

Terminated

Lymphoma, Non-Hodgkin

2013-10-31

2009-011498-34

P2

Completed

Melanoma

2012-08-20

Recent News Events

Date

Type

Title